CASREL is developed, a machine learning framework that infers candidate regulatory circuitry between RNA-binding proteins and alternative splicing from single-cell data, enabling de novo mapping of putative cell-specific regulatory networks.
Abstract
Context-dependent regulation of alternative splicing, largely mediated by RNA-binding proteins, is a key post-transcriptional mechanism shaping diverse biological processes. Experimental approaches for probing splicing regulation, such as crosslinking-immunoprecipitation assays and RNA-binding protein perturbations, suffer from low throughput, poor physiological relevance, and bulk resolution that overlooks cellular heterogeneity. Here, we present CASREL, a machine learning framework that reconstructs candidate regulatory circuitry between RNA-binding proteins and alternative splicing directly from single-cell RNA sequencing data without reliance on prior protein-RNA binding annotations. CASREL integrates ensemble learning with model interpretation based on Shapley additive explanations to infer associations between RNA-binding proteins and alternative splicing, leveraging distinctive features of single-cell splicing profiles, including polarized isoform usage, minimal averaging of regulatory programs, and resilience to expression noise. Applications across diverse tissues and cell types demonstrate its robustness, accuracy, and biological relevance, supporting CASREL as an effective method for de novo mapping of putative cell-specific RNA splicing regulation in physiological contexts. The authors develop CASREL, a machine learning framework that infers candidate regulatory circuitry between RNA-binding proteins and alternative splicing from single-cell data, enabling de novo mapping of putative cell-specific regulatory networks.
Alternative splicing (AS) greatly expands proteomic diversity and is tightly regulated by RNA-binding proteins (RBPs), whose activities reflect both the direction and the strength of their regulatory influence. However, inferring RBP activity remains challenging owing to the incomplete characterization of RBP–splicing...
This review integrates the molecular logic of splice-site selection with the cancer-specific mechanisms that perturb it, summarizes representative isoform switches across the hallmarks of cancer, evaluates emerging technologies and clinical biomarkers, and discusses the opportunities and constraints of translating spli...
RNA splicing is frequently disrupted by genetic variation, contributing to a wide range of human diseases. Identifying the variants responsible for altered splicing is therefore crucial but has long been challenging. Deep learning models that predict splicing from genomic sequence have substantially advanced their dete...
K. Jaganathan, Jian-Bin Chen, Xin Liu et al.· bioRxiv· 0 citations
Findings indicate that the regulatory fate of an sRNA–mRNA interaction is an emergent property of its biophysical context and protein-binding environment, rather than a direct consequence of physical pairing alone.
F. Safari, Daniel G. Mediati, Saleh Alquethamy et al.· bioRxiv· 0 citations
This review describes how spliceosome assembly, splicing regulatory elements, splicing factors, epigenetic modifications, and post-transcriptional processes determine splice-site selection and suggests that safe clinical translation will require greater selectivity, reduced off-target toxicity, and preservation of esse...
Huining Huang, Yao Yu, Qian Zhou et al.· Molecular Biomedicine· 0 citations
Deep long-read RNA sequencing and proteomics in induced pluripotent stem cell-derived cortical neurons is integrated to generate a high-resolution proteogenomic atlas of human neuron development, uncovering thousands of novel isoforms and revealing dynamic splicing changes in autism risk genes.
N. Xu, Katherine M. Rynard, E. Radley et al.· Nature Communications· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.